Respiratory support in COVID-19 patients in Kommunarka hospital: a single-centered, retrospective study

Nikita S. Matiushkov, I. N. Tyurin, S. Avdeikin, A. Boyarkov, D. Kazakov, D. M. Kostin, A. V. Srednyakov, D. Protsenko
{"title":"Respiratory support in COVID-19 patients in Kommunarka hospital: a single-centered, retrospective study","authors":"Nikita S. Matiushkov, I. N. Tyurin, S. Avdeikin, A. Boyarkov, D. Kazakov, D. M. Kostin, A. V. Srednyakov, D. Protsenko","doi":"10.21320/1818-474x-2021-3-47-60","DOIUrl":null,"url":null,"abstract":"Introduction. During the SARS-CoV-2 pandemic, worldwide healthcare system faced a new, insufficiently investigated, fast-spreading disease with multisystem failure and relatively high amount of severe diseased. Existing evidence base needs to be frequently revisited after data accumulation and analysis. Experience of dedicated COVID-19 centers should be summarized and implicated in clinical practice according to evidence-based principles, extensive clinical trial initiation. Objectives. To investigate baseline characteristics and treatment outcomes of patients with severe SARS-CoV-2 infection course, requiring respiratory support in the critical care settings of dedicated hospital. Materials and methods. In single-center retrospective study retrospective data collection of 451 respiratory support for COVID-19 related acute respiratory distress syndrome cases (noninvasive ventilation, mechanical ventilation) in intensive care unit patients for a 5-month period performed. The analysis aimed on demographic, clinical data, disease severity scores, respiratory support parameters and modality, continuous renal replacement therapy utilization and interleukin-6 receptor blockers administration, survival rates. Results. Respiratory support required 48.8 % of intensive care unit patients, the population was demographically balanced, Charlson Comorbidity Index was 4.46 ± 2.6 and was higher in the mechanically ventilated group. 30-day survival rate (all respiratory support cases) was 33.7 %, mortality structure analysis performed. The disease severity scores, respiratory mechanics among patients in dependence of respiratory support mode and during the period of case registration analysed as well. Median static respiratory compliance at the point of initiation of invasive mechanically ventilation was 43 (IQR 35–51). Mortality in the volume controlled mechanically ventilated group was higher. Conclusions. The patients, requiring respiratory support, during intensive care unit stay have high comorbidity levels. Indications for non-invasive ventilation may be extended on patients with lower Charlson index and initial SOFA score, however, early recognition of high risk of noninvasive ventilation failure required. Volume control invasive ventilation associated with higher mortality levels despite comparable disease severity scores. Further investigation required. © 2021, Practical Medicine Publishing House LLC. All rights reserved.","PeriodicalId":93261,"journal":{"name":"Annals of pulmonary and critical care medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of pulmonary and critical care medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21320/1818-474x-2021-3-47-60","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. During the SARS-CoV-2 pandemic, worldwide healthcare system faced a new, insufficiently investigated, fast-spreading disease with multisystem failure and relatively high amount of severe diseased. Existing evidence base needs to be frequently revisited after data accumulation and analysis. Experience of dedicated COVID-19 centers should be summarized and implicated in clinical practice according to evidence-based principles, extensive clinical trial initiation. Objectives. To investigate baseline characteristics and treatment outcomes of patients with severe SARS-CoV-2 infection course, requiring respiratory support in the critical care settings of dedicated hospital. Materials and methods. In single-center retrospective study retrospective data collection of 451 respiratory support for COVID-19 related acute respiratory distress syndrome cases (noninvasive ventilation, mechanical ventilation) in intensive care unit patients for a 5-month period performed. The analysis aimed on demographic, clinical data, disease severity scores, respiratory support parameters and modality, continuous renal replacement therapy utilization and interleukin-6 receptor blockers administration, survival rates. Results. Respiratory support required 48.8 % of intensive care unit patients, the population was demographically balanced, Charlson Comorbidity Index was 4.46 ± 2.6 and was higher in the mechanically ventilated group. 30-day survival rate (all respiratory support cases) was 33.7 %, mortality structure analysis performed. The disease severity scores, respiratory mechanics among patients in dependence of respiratory support mode and during the period of case registration analysed as well. Median static respiratory compliance at the point of initiation of invasive mechanically ventilation was 43 (IQR 35–51). Mortality in the volume controlled mechanically ventilated group was higher. Conclusions. The patients, requiring respiratory support, during intensive care unit stay have high comorbidity levels. Indications for non-invasive ventilation may be extended on patients with lower Charlson index and initial SOFA score, however, early recognition of high risk of noninvasive ventilation failure required. Volume control invasive ventilation associated with higher mortality levels despite comparable disease severity scores. Further investigation required. © 2021, Practical Medicine Publishing House LLC. All rights reserved.
Kommunarka医院COVID-19患者的呼吸支持:一项单中心回顾性研究
介绍。在SARS-CoV-2大流行期间,全球卫生系统面临着一种新的、调查不足的、快速传播的、多系统失效的、严重患病人数相对较高的疾病。现有的证据基础需要在数据积累和分析后经常被重新审视。应根据循证原则,总结新冠肺炎专门中心的经验,并将其纳入临床实践,广泛开展临床试验。目标。目的:调查在专门医院重症监护环境中需要呼吸支持的严重SARS-CoV-2感染病程患者的基线特征和治疗结果。材料和方法。在单中心回顾性研究中,回顾性收集了451例对COVID-19相关急性呼吸窘迫综合征患者进行呼吸支持(无创通气、机械通气)的重症监护病房患者,为期5个月。分析的目的是人口统计学、临床数据、疾病严重程度评分、呼吸支持参数和方式、持续肾脏替代治疗的使用和白细胞介素-6受体阻滞剂的使用、生存率。结果。重症监护病房患者需要呼吸支持的占48.8%,人口统计学平衡,Charlson合并症指数为4.46±2.6,机械通气组较高。30天生存率(所有呼吸支持病例)为33.7%,进行死亡率结构分析。分析了呼吸支持模式依赖患者和病例登记期间的疾病严重程度评分、呼吸力学。有创机械通气开始时的中位静态呼吸顺应性为43 (IQR 35-51)。容量控制机械通气组死亡率较高。结论。在重症监护病房期间需要呼吸支持的患者有很高的合并症水平。对于Charlson指数和SOFA初始评分较低的患者,无创通气适应证可以扩大,但需要早期识别无创通气失败的高风险。容积控制有创通气与较高的死亡率相关,尽管疾病严重程度评分相当。需要进一步调查。©2021,实用医学出版社有限责任公司保留所有权利。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信